200 related articles for article (PubMed ID: 37203438)
1. An iron-containing ferritin-based nanosensitizer for synergistic ferroptosis/sono-photodynamic cancer therapy.
Zheng Y; Zheng J; Du M; Yang Y; Li X; Chen H; Gao Y
J Mater Chem B; 2023 Jun; 11(22):4958-4971. PubMed ID: 37203438
[TBL] [Abstract][Full Text] [Related]
2. A nanoreactor boosts chemodynamic therapy and ferroptosis for synergistic cancer therapy using molecular amplifier dihydroartemisinin.
Yang XX; Xu X; Wang MF; Xu HZ; Peng XC; Han N; Yu TT; Li LG; Li QR; Chen X; Wen Y; Li TF
J Nanobiotechnology; 2022 May; 20(1):230. PubMed ID: 35568865
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-responsive nanoreactors based on self-enhanced photodynamic sensitization and triggered ferroptosis for cancer synergistic therapy.
Wang X; Wu M; Zhang X; Li F; Zeng Y; Lin X; Liu X; Liu J
J Nanobiotechnology; 2021 Jul; 19(1):204. PubMed ID: 34238297
[TBL] [Abstract][Full Text] [Related]
4. A nanosensitizer self-assembled from oleanolic acid and chlorin e6 for synergistic chemo/sono-photodynamic cancer therapy.
Zheng Y; Li Z; Yang Y; Shi H; Chen H; Gao Y
Phytomedicine; 2021 Dec; 93():153788. PubMed ID: 34634745
[TBL] [Abstract][Full Text] [Related]
5. Degradable iron-rich mesoporous dopamine as a dual-glutathione depletion nanoplatform for photothermal-enhanced ferroptosis and chemodynamic therapy.
Cheng H; He Y; Lu J; Yan Z; Song L; Mao Y; Di D; Gao Y; Zhao Q; Wang S
J Colloid Interface Sci; 2023 Jun; 639():249-262. PubMed ID: 36805750
[TBL] [Abstract][Full Text] [Related]
6. Ferroptosis triggered by dihydroartemisinin facilitates chlorin e6 induced photodynamic therapy against lung cancerthrough inhibiting GPX4 and enhancing ROS.
Han N; Li LG; Peng XC; Ma QL; Yang ZY; Wang XY; Li J; Li QR; Yu TT; Xu HZ; Xu X; Chen X; Wang MF; Li TF
Eur J Pharmacol; 2022 Mar; 919():174797. PubMed ID: 35122867
[TBL] [Abstract][Full Text] [Related]
7. Hemin-incorporating DNA nanozyme enabling catalytic oxygenation and GSH depletion for enhanced photodynamic therapy and synergistic tumor ferroptosis.
Xiao X; Chen M; Zhang Y; Li L; Peng Y; Li J; Zhou W
J Nanobiotechnology; 2022 Sep; 20(1):410. PubMed ID: 36109814
[TBL] [Abstract][Full Text] [Related]
8. Ferritin-Hijacking Nanoparticles Spatiotemporally Directing Endogenous Ferroptosis for Synergistic Anticancer Therapy.
Zhu L; You Y; Zhu M; Song Y; Zhang J; Hu J; Xu X; Xu X; Du Y; Ji J
Adv Mater; 2022 Dec; 34(51):e2207174. PubMed ID: 36210735
[TBL] [Abstract][Full Text] [Related]
9. Bioactive Iridium Nanoclusters with Glutathione Depletion Ability for Enhanced Sonodynamic-Triggered Ferroptosis-Like Cancer Cell Death.
Nie T; Zou W; Meng Z; Wang L; Ying T; Cai X; Wu J; Zheng Y; Hu B
Adv Mater; 2022 Nov; 34(45):e2206286. PubMed ID: 36134532
[TBL] [Abstract][Full Text] [Related]
10. Iron-based nanoparticles for MR imaging-guided ferroptosis in combination with photodynamic therapy to enhance cancer treatment.
Chen Q; Ma X; Xie L; Chen W; Xu Z; Song E; Zhu X; Song Y
Nanoscale; 2021 Mar; 13(9):4855-4870. PubMed ID: 33624647
[TBL] [Abstract][Full Text] [Related]
11. Potent nanoreactor-mediated ferroptosis-based strategy for the reversal of cancer chemoresistance to Sorafenib.
Wang X; Zhao L; Wang C; Wang L; Wu H; Song X; Wang W; Xu H; Dong X
Acta Biomater; 2023 Mar; 159():237-246. PubMed ID: 36736851
[TBL] [Abstract][Full Text] [Related]
12. Fe-MnO
Huang D; Xu D; Chen W; Wu R; Wen Y; Liu A; Lin L; Lin X; Wang X
Biomed Pharmacother; 2023 May; 161():114431. PubMed ID: 36827713
[TBL] [Abstract][Full Text] [Related]
13. Lipid Peroxidation and Iron Metabolism: Two Corner Stones in the Homeostasis Control of Ferroptosis.
Rochette L; Dogon G; Rigal E; Zeller M; Cottin Y; Vergely C
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613888
[TBL] [Abstract][Full Text] [Related]
14. Ferroptosis: Role of lipid peroxidation, iron and ferritinophagy.
Latunde-Dada GO
Biochim Biophys Acta Gen Subj; 2017 Aug; 1861(8):1893-1900. PubMed ID: 28552631
[TBL] [Abstract][Full Text] [Related]
15. A reactive oxygen species-replenishing coordination polymer nanomedicine disrupts redox homeostasis and induces concurrent apoptosis-ferroptosis for combinational cancer therapy.
Zhang Z; Pan Y; Cun JE; Li J; Guo Z; Pan Q; Gao W; Pu Y; Luo K; He B
Acta Biomater; 2022 Oct; 151():480-490. PubMed ID: 35926781
[TBL] [Abstract][Full Text] [Related]
16. GSH/pH Dual Activatable Cross-linked and Fluorinated PEI for Cancer Gene Therapy Through Endogenous Iron De-Hijacking and in Situ ROS Amplification.
Yang S; Wu Y; Zhong W; Chen R; Wang M; Chen M
Adv Mater; 2024 Jan; 36(2):e2304098. PubMed ID: 37689975
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress-amplified nanomedicine for intensified ferroptosis-apoptosis combined tumor therapy.
Yu M; Yu J; Yi Y; Chen T; Yu L; Zeng W; Ouyang XK; Huang C; Sun S; Wang Y; Liu Y; Lin C; Wu M; Mei L
J Control Release; 2022 Jul; 347():104-114. PubMed ID: 35513212
[TBL] [Abstract][Full Text] [Related]
18. Manganese porphyrin-based metal-organic framework for synergistic sonodynamic therapy and ferroptosis in hypoxic tumors.
Xu Q; Zhan G; Zhang Z; Yong T; Yang X; Gan L
Theranostics; 2021; 11(4):1937-1952. PubMed ID: 33408790
[TBL] [Abstract][Full Text] [Related]
19. pH-Responsive Sorafenib/Iron-Co-Loaded Mesoporous Polydopamine Nanoparticles for Synergistic Ferroptosis and Photothermal Therapy.
Liu S; Liu Y; Chang Q; Celia C; Deng X; Xie Y
Biomacromolecules; 2024 Jan; 25(1):522-531. PubMed ID: 38087829
[TBL] [Abstract][Full Text] [Related]
20. ROS-responsive fluorinated polyethyleneimine vector to co-deliver shMTHFD2 and shGPX4 plasmids induces ferroptosis and apoptosis for cancer therapy.
Yang S; Wong KH; Hua P; He C; Yu H; Shao D; Shi Z; Chen M
Acta Biomater; 2022 Mar; 140():492-505. PubMed ID: 34879292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
